Phase 3 Readout~month
Phase 3 Topline: Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radi
- Company
- CG Oncology, Inc. (CGON)
- Indication
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Other upcoming events for CGON
Phase 3 ReadoutPhase 3 Topline: Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for
Phase 3 ReadoutPhase 3 Topline: Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prosta
Phase 3 ReadoutPhase 3 Topline: ALTernate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuva
Phase 3 ReadoutPhase 3 Topline: An Open-label, Rollover Study of Futibatinib in Patients Previously Enrolled in an Antecedent Futiba
Phase 3 ReadoutPhase 3 Topline: Randomized, Controlled, Open-label, Phase 3, Global Multi - Center Trial to Assess the Efficacy and
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.